期刊名称：CURRENT ALZHEIMER RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
Current Alzheimer Research publishes peer-reviewed frontier review and research articles on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.
Instructions to Authors
Instructions for Authors
Manuscripts should be submitted openly to one of the following Editors without prior invitation at the following addresses:
Prof. Debomoy K. Lahiri
Professor of Neurobiology and Medical & Molecular Genetics
Indiana University School of Medicine
Institute of Psychiatric Research
Department of Psychiatry
791 Union Drive
Indianapolis
IN-46202
USA
Tel: +1 317-274-2706
Fax: +1 317-274-1365
E-mail: dlahiri@iupui.edu
Unless invited to provide a review it is preferable to send a brief outline of any text you propose to submit to the Editor-in-Chief. Topic headers will be sufficient. The approximate date of submission of your review should also be included. The text must be written in the Vancouver style throughout the manuscript.
Regular Reviews and Mini-Reviews: For Regular Review¡'articles, the manuscript, written in English, should not exceed 50 pages (ca. 25 printed pages) and for Mini-Reviewsa maximum of 20 manuscript pages in length (ca. 10 printed pages). Mini-reviewscan deal with an emerging area within AD research and Regular Revie articles can cover up to two areas of AD research.
Original Articles: The journal considers the publication of Original Research Papers, which represent scientifically rigorous novel research that addresses disease mechanisms from biochemical, genetic, and molecular levels using both cellular and in vivo systems. The journal also welcomes recent research work in fast emerging areas of molecular diagnostics, brain imaging, drug development discovery and clinical aspects of Alzheimer's disease.
Single Topic Issues: These issues will be restricted to invited review articles. A Single Topic Special Editor will offer a short Perspective and co-ordinate the solicitation of between 6 to 10 manuscripts from leading scientists. Authors interested in editing a single topic issue in an emerging topic of AD research may submit their proposal to the Editor-in-Chief for his consideration.
Letters to the Editor: The journal will also consider for publication letters (no more than one page) that comment on reviews published in this journal. Authors/readers are encouraged to comment/ debate/ challenge any of the published articles of this journal.
Book Reviews and Conference Reports: Anyone who wants to write a book review or a report on a relevant conference should contact the Editor first.
The manuscript should be typed in double spacing throughout on A-4 or US Letter (8.5x11 inches) paper. Dot matrix print or any print that is difficult to read is unacceptable. Two copies of the manuscript must accompany the original along with a computer disk and should be sent to the Editor-in-Chief at his address. All pages should be numbered. Abbreviations should be defined the first time that they are used in the manuscript and a list of abbreviations used should be provided (see below).
Manuscript Organization: The manuscript should be divided as: Title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed. This should be followed by the Acknowledgement (if any) and Reference sections. The first page should contain the title, the authors¡¯ names (initials and surname only), with an asterisk to mark the name of the principal author.
Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.
Abstract: The abstract should not exceed 250 words and it should condense the essential features of the review article, with the focus on the major advances in the field.
Key Words: Authors must supply up to eight key words along with their manuscript.
Text: The main text should begin on a separate page and it may be subdivided but not into the separate sections. The review article should mention any previous important reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments. References should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the Reference section.
Tables:
- Data Tables should be submitted in Microsoft Excel or in Microsoft Word table format.
- Each table should include a title/caption explaining what the table shows. Detailed legends may then follow.
- Tables should be given on separate pages with indications on the left hand margin to the text, as to the appropriate placement of the tables.
- Tables should not contain vertical rules.
- Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines.
- Tables should be numbered consecutively in order of their citation in the body of the text, with Arabic numerals.
- If a reference is cited in both the table and text, insert a lettered footnote in the table to refer to the numbered reference in the text.
- Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Figures / Illustrations:
All authors must strictly follow the guidelines below for preparing illustrations for publication in Current Alzhimer Resarch.
Editorial Requirements:
The quality of the illustrations printed in the journal largely depends on the quality of the figures/illustration provided by the author. In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic print of the original for publication.
- Do not submit photocopies. (Hardcopy submission requirement).
- Illustrations should be provided as separate files, not embedded in the text. (Hardcopy submission requirement).
- Remove all color from graphics except for those illustrations (Greyscale), which are intended to be printed in color.
- Good quality of hardcopy originals are a requirement.
- Figures should be referred to as Fig. (1), Fig. (2) etc. in the text with figure numbers in bold within round bracket.
- Revised manuscripts should contain a complete set of artwork and photographs.
Technical Details:
- Figures should be provided on high quality, white, smooth opaque paper. (Hardcopy requirement).
Format & Resolution:
- The following file formats can be accepted. (Preference in order of appearance): PDF, TIFF, JPEG, GIF.
- Illustrations must fit a single or double column format on the journal page, according to the following guideline below:
|
HEIGHT |
WIDTH |
|
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) |
|
DOUBLE COLUMN |
24 cm (max) |
18 cm (max) |
- Whenever possible, submit graphics that do not have to be reduced to fit the standard figure size.
- Use the best resolution available (hardcopy submission requirement). For online submission the maximum resolution is 300 dpi.
- Avoid textures and shadings giving a three-dimensional effect to the illustration.
- Symbols and lettering in the illustration should be of similar size.
- Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
- Line drawings should have clear and sharp lines and should be of uniform density. Moreover, lines should be continuous without any breaks.
- Do not use lines thinner than 1 point.
Color Figures / Illustrations:
Photographs:
Submit high-contrast prints that are of single- or double-column width so that they will not have to be reduced when printed. Negatives are not acceptable. However, in case of hardcopy submission, color illustrations and plates can be published from 35 mm color slides.
Structures: Structures should be presented separately, drawn using a suitable graphics program (e.g. ChemDraw) and printed with a laser printer. The structures should fit into a width of 8 cm (for structures to be inserted within single column widths) or a width of 18 cm (for structures or schemes to be inserted in double column widths).
References: References should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the reference section. All references must be complete and accurate. Online citations should include date of access. Journal titles should conform to the present Index Medicus abbreviations. It is necessary to list all authors if the total number of authors is 6 or less and for more than six authors use et al. References should be listed in the following Vancouver style:
Typical Paper Reference:
Boehm M and Nabel EG. Angiotensin-converting enzyme 2-a new cardiac regulator. N Engl J Med 347: 1795-1797 (2002).
Lahiri DK, Farlow MR, Greig NH, Giacobini E and Schneider LS. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr Drug Targets 4: 97-112 (2003).
Typical Book Reference:
Stevenson WG and Friedman PL. In: ¡®Clinical trials in cardiovascular disease(Ed: Hennekens CH), WB Saunders Co. Philadelphia, p. 217-230 (1999).
Typical Chapter Reference:
Lahiri DK, Ge Y, Nurnberger JI, Yang EY, Walsh TJ and Bondy SC. Melatonin, nitric oxide synthase and oxidative stress. In ¡®Catecholamine Research: From Molecular Insights to Clinical Medicine (Eds: Nagatsu T, Nabeshima T, McCarty R and D Goldstein, D), Kluwer Academic/ Plenum Publishers, New York, p. 245-248 (2002).
Abstracts, unpublished data and personal communications (which can only be included if prior permission has been obtained) should not be given in the references section but they may be mentioned in the text and details provided as footnotes.
Manuscript Submission: Authors may submit a list of 4-5 potential reviewers who are expert in the field and can promptly review the manuscript. Also they can provide a list of investigators with 'conflict of interest. Two copies of the manuscript must accompany the original along with the soft copy of the manuscript on a computer floppy disk(s) in MS Word file format (or created in any other well-known word processing software) should be submitted. To achieve rapid publication authors are encouraged to e-mail or fax their submission to the appropriate editorial office (see above) at the same time that they mail the manuscript. For even faster publication, authors are encouraged to submit their entire manuscript via Bentham¡¯s online submission service (see below). Authors must provide their full address, telephone and fax numbers with e-mail address with all submissions.
For expedient and speedy reviewing of author's manuscripts, authors are strongly advised to include the PDF file of their manuscript on a floppy or zip disk, into the mailing material. At the same time the package is mailed, please also send by e-mail a copy of the PDF file of the manuscript to the editorial office.
Online Manuscript Submission: (preferable)
To facilitate speedy and cost-effective submission of abstracts and manuscripts, an online submission and tracking service via Internet is being offered. Once the Editor-in-Chief of the journal has accepted your abstract, we would prefer that you submit your full manuscript online via our online submission service available at www.bentham-mps.org
For online submission, please provide your complete manuscript in the form of a single zipped folder containing all the material (main text, figures/ illustrations, scanned photographs, tables, chemical structures drawn in ChemDraw) as separate files and a PDF version of the entire manuscript with all the figures/ illustrations / tables / chemical structures etc., embedded in the text exactly in the manner as they should appear in printing.
Authors are required to proofread the PDF version of their manuscript before submission. The article will be published exactly as received and the Publishers will not be responsible for any error occurring in the manuscript in this regard.
For online submission of manuscripts, these should be submitted via our online manuscript submission service available at www.bentham-mps.org or by FTP submission at www.bentham-ftp.org
You may, however, still submit your abstracts and manuscripts through conventional surface mail.
Page Charges: No page charges will be levied to authors.
Language Editing: Manuscripts submitted containing many English typographical errors will not be published. Authors from non-English language countries are advised to use the services of our professional language editing department prior to submitting their manuscript to the Journal. Please contact Bentham Publishing Services www.bentham.org/bps for a language editing quote at e-mail: bps@bentham.org stating the total number of words of the article to be edited.
Proofs: Authors are sent page proofs. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Authors will be charged for excessive changes made at the page proof stage.
Reprints: Each first named author will receive by e-mail a free copy of their article as a PDF file. The PDF file is a watermarked version of the published article which is exclusively for the author's own use and may not be copied or distributed. Reprints may be ordered from the Publisher prior to publication of the article. First named authors may also order a personal print and online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: subscriptions@bentham.org
Bentham Open Access: Accepted articles can be published online for an immediate free open access for all to view. Open access publishing provides the maximum dissemination of the article to the largest audience. Authors must pay for this service. For more information please contact us at e-mail: openaccess@bentham.org
Reviewing and Promptness of Publication: All papers submitted for publication will be immediately subjected to editorial scrutiny, usually in consultation with members of the Editorial Advisory Board. Every effort will be made to assess the papers quickly. The papers will be typeset and the proofs dispatched to the authors normally within 4 weeks of their acceptance.
Copyright: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
Editorial Board
Editor-in-Chief:
Prof. Debomoy K. Lahiri
Department of Psychiatry
Indiana University School of Medicine
Indianapolis, IN
USA
Editors for Europe:
Konrad Beyreuther (University Heidelberg, Heidelberg, Germany)
Frederic Checler (Institut de Pharmacologie Moleculaire et Cellulaire, Valbonne, France)
Editors for Asia and Australia:
Colin L. Masters (University of Melbourne, Melbourne, Victoria, Australia)
Toshitaka Nabeshima (Nagoya University Graduate School of Medicine, Nagoya, Japan)
Associate Editors:
Kevin M. Felsenstein (Johnson & Johnson Pharma., Spring House, PA, USA)
Abraham Fisher ( Israel Institute for Biology Research, Ness-Ziona, Israel)
Nigel H. Greig (National Institute on Aging/ NIH, Baltimore, MD, USA)
Frank M. LaFerla (University of California, Irvine, CA, USA)
George Perry (University of Texas at San Antonio, Texas, USA)
Dale Schenk (Elan Pharmaceuticals, San Francisco, USA)
L.S. Schneider (Univ. of S.California Keck Sch. of Med., Los Angeles, CA, USA)
Thomas Wisniewski (New York Univ. Sch. of Med., New York, NY, USA)
Editorial Advisory Board:
Larry Altstiel (Schering-Plough, Kenilworth, NJ, USA)
Craig Atwood (Univ. of Wisconsin-Madison Sch. of Med., Madison, WI, USA)
Clive Ballard (King's College, London, UK)
Steven W. Barger (Univ. of Arkansas for Medical Sciences, Little Rock, AR, USA)
David A. Bennett (Rush University Medical Center, Chicago, USA)
Ramon Cacabelos (EuroEspes Biomedical Research Center, La Coruna, Spain)
Suzanne Crraft (University of Washington, Seattle, WA, USA)
A. Claudio Cuello (McGill University, Montreal, Quebec, Canada)
Luciano D'Adamio (Albert Einstein College of Medicine, Bronx, NY, USA)
Steven T. DeKosky (University of Pittsburgh, Pittsburgh, PA, USA)
Dennis Dickson (Mayo Clinic, Jacksonville, FL, USA)
Christopher Eckman (Mayo Clinic Jacksonville, Jacksonville, FL, USA)
Martin R. Farlow (Indiana University School Medicine, Indianapolis, IN, USA)
Robert Friedland (University Hospital of Cleveland, CWRU, Cleveland, OH, USA)
Samuel E. Gandy (Thomas Jefferson University, Philadelphia, PA, USA)
Bernardino Ghetti (Indiana University School of Medical Center, Indianapolis, IN, USA)
Jorge Ghiso (NYU Medical Center, New York, NY, USA)
Ezio Giacobini (HUG, Geneva University Hospital, Geneva, Switzerland)
Todd E. Golde (Mayo Clinic Jacksonville, Jacksonville, FL, USA)
John Hardy (National Institute on Ageing, Bethesda, MD, USA)
Tobias Hartmann (University of Heidelberg, Heidelberg, Germany)
Nibaldo C. Inestrosa (Catholic University of Chile, Santiago, Chile)
Khalid Iqbal (NYS Institute for Basic Research, Staten Island, NY, USA)
Steve Jacobsen (Wyeth Ayerst, Princeton, NJ, USA)
Girish J. Kotwal (University of Cape Town, Cape Town, South Africa)
Dora M. Kovacs (Massachusetts General Hospital, Charlestown, MA, USA)
Andrea C. LeBlanc (McGill University, Montreal, Quebec, Canada)
Eckhard Mandelkow (Max-Planck-Unit for Str. Mol. Biology, Hamburg, Germany)
David Mann (Greater Manchester Neurosciences Centre, Hope Hospital, Salford, UK)
Patrick L. McGeer (University of British Columbia, Vancouver, BC, Canada)
Eliezer Masliah (University of California San Diego, La Jolla, CA, USA)
Mark Mattson (National Institute on Aging, Gerontology Research Center, Baltimore, MD, USA)
Daniel Michaelson (Tel Aviv University, Tel Aviv, Israel)
Richard C. Mohs (Lilly Research Laboratories, Indianapolis, IN, USA)
David Morgan (University of South Florida, Tampa, FL, USA)
William van Nostrand (Stony Brook University, Stony Brook, NY, USA)
Agneta Nordberg (Karolinska Institute, Huddinge, Sweden)
Yasumasa Ohyagi (Kyushu University, Fukuoka, Japan)
George Perry (University of Texas at San Antonio, Texas, USA)
Miguel Pappolla (University of South Alabama, Mobile, AL, USA)
Steven Paul, (Eli Lilly & Company, Indianapolis, IN, USA)
Suzana Petanceska (National Institute on Aging, Bethesda, MD, USA)
Judes Poirier (McGill Center for Studies in Aging, Montreal, Quebec, Canada)
Lorenzo M. Refolo (National Institute of Neurological Disorders and Stroke, NIH, Rockville, MD, USA)
Nikolaos K. Robakis (Mount Sinai School of Medicine, New York, NY, USA)
Takaomi C. Saido (RIKEN Brain Science Institute, Saitama, Japan)
Kumar Sambamurti (Medical Univ. of South Carolina, Charleston, SC, USA)
G.D. Schellenberg (Veterans Affairs Puget Sound Health Care Sys., Seattle, WA, USA)
Michael L. Shelanski (Columbia University, New York, NY, USA)
David H. Small (Monash University, Melbourne, Australia)
Gary W. Small (University of California Los Angeles, Los Angeles, CA, USA)
Mark A. Smith (Case Western Reserve University, Cleveland, OH, USA)
Hermona Soreq (The Hebrew University of Jerusalem¡¯s Science Faculty, Jerusalem, Israel)
Larry D. Sparks (Sun Health Research Institute, Sun City, AZ, USA)
Warren Strittmatter (Duke University Medical Center, Durham, NC, USA)
Takeshi Tabira (National Institute for Longevity Sciences, Aichi, Japan)
Jordan Tang (Oklahoma Medical Research Foundation, Oklahoma City, OK, USA)
Rudolph E. Tanzi (Harvard Medical School, Charlestown, MA, USA)
Denis Vivien (INSERM-Avenir, GIP Cyceron / Universit¨¦ de Caen, Caen, France)
Bengt Winblad (Karolinska Institute, Stockholm, Sweden)
Benjamin Wolozin (Boston University School of Medicine, Boston, MA, USA)
Paolo Zatta (University of Padova, Padova, Italy)
|
